Drug intelligence / Profile preview

B-PKOPO

Development stage: Preclinical
Administration: Oral

Overview

B-PKOPO is a physical blend of palm kernel oil and palm oil, characterized by a fatty acid composition similar to Medium-and-Long Chain Triacylglycerol (MLCT). It has been investigated in studies for its potential anti-obesity effects. Research in Diet Induced Obesity (DIO) C57BL/6J mice compared B-PKOPO to other MLCTs, noting its influence on body weight gain and body fat accumulation. However, it was also observed to be hypercholesterolemic compared to commercial MLCTs, a characteristic attributed to its higher myristic acid content.

Other names: physical blend of palm kernel and palm oil

Beyond the preview

Go deeper on B-PKOPO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-PKOPO.

Explore the full profile